Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors.
Arch Pharm (Weinheim)
; 353(5): e2000005, 2020 May.
Article
in En
| MEDLINE
| ID: mdl-32175625
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Design
/
Proto-Oncogene Proteins c-bcl-2
/
Phenalenes
/
Myeloid Cell Leukemia Sequence 1 Protein
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Arch Pharm (Weinheim)
Year:
2020
Type:
Article
Affiliation country:
China